MAXESTATES.BO(MAXESTATES.BO)
MAXESTATES.BO
No analyst ratings available
No analyst price targets available for MAXESTATES.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $2.29B | $21.25B | $28.38B |
| Low | $2.08B | $20.51B | $21.15B |
| High | $2.59B | $21.88B | $35.61B |
| EBITDA Avg | $1.32B | $9.78B | $19.80B |
| Low | $960M | $8.77B | $13.93B |
| High | $1.39B | $10.79B | $27.60B |
| EBIT Avg | $671M | $5.63B | $11.63B |
| Low | $309M | $4.62B | $5.76B |
| High | $740M | $6.64B | $19.43B |
| Net Income Avg | $78M | $3.80B | $8.30B |
| Low | $-259M | $3.04B | $3.89B |
| High | $129M | $4.55B | $14.14B |
| EPS Avg | $-0.23 | $23.03 | $55.75 |
| Low | $-1.60 | $18.79 | $24.07 |
| High | $0.80 | $28.15 | $87.43 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 4 | 2 / 2 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $868M |
| Low | $868M |
| High | $868M |
| EBITDA Avg | — |
| Low | — |
| High | — |
| EBIT Avg | — |
| Low | — |
| High | — |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |